Report cover image

Hematology Analyzers and Reagents Market Report by Product (Haematology, Haemostasis, Immunohaematology), Usage Type (Standalone, Point-of-care), Price Range (Low Range, Mid-Range, High Range), Application (Haemorrhagic Conditions, Infection-Related Condi

Publisher IMARC Services Pvt. Ltd.
Published Sep 04, 2023
Length 146 Pages
SKU # IMRC18188821

Description

Hematology Analyzers and Reagents Market Report by Product (Haematology, Haemostasis, Immunohaematology), Usage Type (Standalone, Point-of-care), Price Range (Low Range, Mid-Range, High Range), Application (Haemorrhagic Conditions, Infection-Related Conditions, Immune System-Related Conditions, Blood Cancer, Anaemia), End User (Commercial Service Providers, Hospital Laboratories, Research and Academic Institutes, and Others), and Region 2023-2028


Market Overview:

The global hematology analyzers and reagents market size reached US$ 8.25 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.16 Billion by 2028, exhibiting a growth rate (CAGR) of 6.80% during 2023-2028. Rising prevalence of blood disorders, the growing geriatric population, rapid advancements in technology, surging demand for point-of-care testing (POCT) devices and portable hematology analyzers, and the increasing adoption of automated hematology analyzers in laboratories and hospitals are some of the key factors driving the market.

Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems.

Hematology Analyzers and Reagents Market Trends:
The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global hematology analyzers and reagents market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, usage type, price range, application, and end user.

Product Insights:

Haematology
Haemostasis
Immunohaematology

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the product. This includes haematology, haemostasis, and immunohaematology. According to the report, haematology represented the largest segment.

Usage Type Insights:

Standalone
Point-of-care

A detailed breakup and analysis of the hematology analyzers and reagents market based on the usage type has also been provided in the report. This includes standalone and point-of-care. According to the report, standalone accounted for the largest market share.

Price Range Insights:

Low Range
Mid-Range
High Range

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the price range. This includes low range, mid-range, and high range. According to the report, low range represented the largest segment.

Application Insights:

Haemorrhagic Conditions
Infection-Related Conditions
Immune System-Related Conditions
Blood Cancer
Anaemia

A detailed breakup and analysis of the hematology analyzers and reagents market based on the application has also been provided in the report. This includes haemorrhagic conditions, infection-related conditions, immune system-related conditions, blood cancer, and anaemia. According to the report, haemorrhagic conditions accounted for the largest market share.

End User Insights:

Commercial Service Providers
Hospital Laboratories
Research and Academic Institutes
Others

The report has provided a detailed breakup and analysis of the hematology analyzers and reagents market based on the end user. This includes commercial service providers, hospital laboratories, research and academic institutes, and others. According to the report, commercial service providers represented the largest segment.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for hematology analyzers and reagents. Some of the factors driving the North America hematology analyzers and reagents market included the surging demand for personalized medicine and companion diagnostics, the increasing number of clinical trials and drug development activities, and the rising demand for hematology analyzers and reagents in veterinary diagnostics.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global hematology analyzers and reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Bio-Rad Laboratories Inc., Boule Diagnostics, Danaher Corporation, Diatron MI PLC (Stratec SE), EKF Diagnostics Holdings plc, Heska Corporation, Horiba Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens, Sinnowa Medical Science & Technology Co. Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global hematology analyzers and reagents market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global hematology analyzers and reagents market?
What is the impact of each driver, restraint, and opportunity on the global hematology analyzers and reagents market?
What are the key regional markets?
Which countries represent the most attractive hematology analyzers and reagents market?
What is the breakup of the market based on product?
Which is the most attractive product in the hematology analyzers and reagents market?
What is the breakup of the market based on the usage type?
Which is the most attractive usage type in the hematology analyzers and reagents market?
What is the breakup of the market based on price range?
Which is the most attractive price range in the hematology analyzers and reagents market?
What is the breakup of the market based on application?
Which is the most attractive application in the hematology analyzers and reagents market?
What is the breakup of the market based on end user?
Which is the most attractive end user in the hematology analyzers and reagents market?
What is the competitive structure of the global hematology analyzers and reagents market?
Who are the key players/companies in the global hematology analyzers and reagents market?

Table of Contents

146 Pages
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hematology Analyzers and Reagents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Haematology
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Haemostasis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunohaematology
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Usage Type
7.1 Standalone
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Point-of-care
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Price Range
8.1 Low Range
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Mid-Range
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 High Range
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Haemorrhagic Conditions
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Infection-Related Conditions
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Immune System-Related Conditions
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Blood Cancer
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Anaemia
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Commercial Service Providers
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospital Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Research and Academic Institutes
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 Drivers, Restraints, and Opportunities
12.1 Overview
12.2 Drivers
12.3 Restraints
12.4 Opportunities
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Bio-Rad Laboratories Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Boule Diagnostics
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Danaher Corporation
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Diatron MI PLC (Stratec SE)
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 EKF Diagnostics Holdings plc
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Heska Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Horiba Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Mindray Medical International Limited
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Nihon Kohden Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Siemens
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Sinnowa Medical Science & Technology Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us